Role of beta-2-microglobulin as a biomarker in very preterm and extremely preterm infants with CNS inflammation

Abstract

In this population, CSF B2M proved to be an effective biomarker to discriminate between patients with CNS infections and other inflammatory processes and those without CNS inflammation.